v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 16,334,353 $ 17,958,989
Other receivable from joint venture 400,000
Prepaid expenses and other current assets 344,652 47,371
Total Current Assets 16,679,005 18,406,360
Other Assets    
Patent costs 1,802,907 1,798,484
Total Assets 18,481,912 20,204,844
Current Liabilities    
Accounts payable and accrued liabilities 485,693 350,299
Total Current Liabilities 485,693 350,299
Commitments and contingencies - (Note 5)
Stockholders Equity    
Common stock, $0.001 par value, 8,333,333 authorized, 3,363,679 and 3,252,371 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 3,364 3,252
Additional paid-in capital 134,338,275 133,932,615
Accumulated deficit (116,348,832) (114,084,746)
Total Stockholders' Equity 17,996,219 19,854,545
Total Liabilities and Stockholders' Equity 18,481,912 20,204,844
Series B Preferred Shares [Member]    
Stockholders Equity    
Preferred stock value 2,667 2,667
Preferred Stock Series A [Member]    
Stockholders Equity    
Preferred stock value $ 745 $ 757

Source